News
Latest News from EU FP7: Updated February 9th 20101

The 1st EACR-OECI Joint Training Course accreditated by ACOE

New communication resources
Skip Navigation Links
Home
OECIExpand  OECI
MembershipExpand  Membership
Board
Working Groups and ActivitiesExpand Working Groups and Activities
Upcoming Events
General AssembliesExpand General Assemblies
Past Events
Links
Contact UsExpand Contact Us
Projects
The TRANSFOG project aims at the systematic identification and functional characterization of novel cancer genes with high potential diagnostic and therapeutic value in breast, colon and lung cancer. The TRANSFOG partner will bring together world recognised competences and resources to reach the integrated research objectives.
TRANSFOG aims at the systematic identification and functional characterization of novel cancer genes with high potential diagnostic and therapeutic value. The main ambition of this project is to re-establish European leadership in the field of cancer genomics. To this aim, the project is integrating academic and industrial cutting edge groups to develop a joint effort towards systematic identification and functional characterization of novel cancer genes with high potential diagnostic and therapeutic value in breast, colon and lung cancer. The project is based on the scientific excellence of the applicants, who have made major recognized contributions to the field and on the construction of shared technological platforms.(...)
TRANSFOG brings together world-recognised competences and resources to reach the following, integrated research objectives:
1 Identification of novel cancer-related genes of high clinical-diagnostic potential, with a specific focus on progression and metastasis of colon, breast, lung cancer.
2 Set-up of technologies for systematic cancer gene functional analysis and identification of new molecular targets.
3 Systematic exploration of oncogenic/antioncogenic signalling pathways, epigenetic regulatory mechanisms to generate a comprehensive overview of the alterations in signalling and regulatory networks involved in cancer progression.
4 Development of tools for diagnostic validation of molecular signatures for cancers of high population impact, such as colon, breast and lung. This enables translation into clinical use of signatures obtained through the cancer-oriented genomic screenings performed by the Partners.
5 Establishment of a shared bioinformatic platform for functional oncogenomics data handling and standardization.
The TRANSFOG experimental pipeline consists of seven research components that synergistically enable streamlined translation of large-scale genomic screenings into highimpact contributions to cancer diagnosis and therapy.
Login restricted to the OECI members
Upcoming Events

  • 1st European Association for Cancer Research (EACR) – Organisation of European Cancer Institutes (OECI)
    Joint Training Course - “Molecular Pathology Approach to Cancer” recommended 13 European CME credits by ACOE
    Amsterdam, March 7th – 9th 2011
    Course Web Site

  • Bilateral Meeting Organisation of European Cancer Institutes - American Association of Cancer Institutes
    “Organization of Comprehensiveness: comparison between OECI and AACI”
    Amsterdam, June 16th 2011

  • Scientific Conference OECI 2011
    “Organization of CCCs: the road map for innovation and the development of personalized cancer medicine”
    Amsterdam, June 17th 2011

  • OECI General Assembly (restricted to OECI Members and Associated Members)
    Amsterdam, June 18th 2011

  • FEBS Advanced Lecture Course "TRANSLATIONAL CANCER RESEARCH"
    Hotel Porto Bay Falesia, Algarve
    September 27 to October 4, 2011
    Announcement

Developed and maintained by MEDINFO - DIST
Comments on the web
Web site optimized for Firefox and Explorer Browsers Updated: 06 March 2011
Comments on the contents